Filing Details

Accession Number:
0001553350-23-000471
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-13 16:02:05
Reporting Period:
2023-12-11
Accepted Time:
2023-12-13 16:02:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1644963 Avenue Therapeutics Inc. ATXI Pharmaceutical Preparations (2834) 474113275
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2002210 L Robert Davidow 2100 South Ocean Blvd., Apartment 401 N
Palm Beach FL 33480
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-11 264,000 $0.14 681,000 No 4 S Direct
Common Stock Disposition 2023-12-11 18,000 $0.15 22,000 No 4 S Indirect Joint account with spouse
Common Stock Disposition 2023-12-11 61,000 $0.14 74,000 No 4 S Indirect Trustee for Juliet Davidow 2001 Trust and Alexander Davidow 2010 Trust
Common Stock Disposition 2023-12-11 126,000 $0.14 215,800 No 4 S Indirect Shared investment and voting authority
Common Stock Disposition 2023-12-11 128,000 $0.14 147,000 No 4 S Indirect Shared investment authority
Common Stock Disposition 2023-12-11 20,000 $0.14 80,000 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect Joint account with spouse
No 4 S Indirect Trustee for Juliet Davidow 2001 Trust and Alexander Davidow 2010 Trust
No 4 S Indirect Shared investment and voting authority
No 4 S Indirect Shared investment authority
No 4 S Indirect By Spouse
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
  2. Consists of shares of common stock held in a joint account with the Reporting Person's wife.
  3. Consists of shares of common stock held in trusts for the benefit of the Reporting Person's children in which the Reporting Person is the trustee.
  4. Consists of shares of common stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared voting and dispositive authority.
  5. Consists of shares of commons stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared dispositive authority.
  6. Consists of shares of common stock held by the Reporting Person's wife.